Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EmSam in Bipolar Depression
NCT00535262Phase 4Terminated
- Sponsor
- New York State Psychiatric Institute
- Start
- Mar 2007
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of selegiline transdermal patch in bipolar disorder (BD), sponsored by New York State Psychiatric Institute. Started Mar 2007; status: terminated.
02
Drugs
selegiline transdermal patch
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00535262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00535262.